PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib 125mg|DRUG: Aromatase Inhibitors|DRUG: Fulvestrant Injectable Product
Sponsor: UNICANCER
Collaborators: Pfizer